drugset / Trial / NCT02253082

Vasculopathic Injury and Plasma as Endothelial Rescue - OCTAplas Trial (EudraCT no. 2014-000452-28)

NCT02253082

Phase 4 Completed 44 enrolled Rigshospitalet, Denmark Octapharma · collab
RandomizedFactorialSingle-blindTreatment

Summary

Effects of OctaplasLG® on endothelial integrity in patients undergoing emergency surgery for thoracic aortic dissections - a randomized, controlled, single-blinded investigator-initiated pilot trial

Timeline

Start
2014-11
Primary completion
2016-09
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fresh Frozen Plasma Protein / enzyme biologic
Comparator Octaplas LG Other / unclassified